Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-02-12

FDA Approved: TACROLIMUS — Original Application (Nexus Pharmaceuticals, LLC)

View source ↗

Summary

Generic tacrolimus from Nexus Pharmaceuticals has been approved through an original ANDA for use in preventing organ transplant rejection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tacrolimus (Tacrolimus)

Snippet

ORIG AP for TACROLIMUS (TACROLIMUS)